• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乙型肝炎病毒感染小鼠模型中,阻断Tim-3信号通路可改善肝脏CD8+ T细胞产生干扰素-γ的情况。

Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection.

作者信息

Ju Ying, Hou Nan, Zhang Xiao Ning, Zhao Di, Liu Ying, Wang Jin Jin, Luan Fang, Shi Wei, Zhu Fa Liang, Sun Wen Sheng, Zhang Li Ning, Gao Cheng Jiang, Gao Li Fen, Liang Xiao Hong, Ma Chun Hong

机构信息

Institute of Immunology, Shandong University School of Medicine, 44 Wenhua Xi Road, Jinan, Shandong 250012, China.

出版信息

Cell Mol Immunol. 2009 Feb;6(1):35-43. doi: 10.1038/cmi.2009.5.

DOI:10.1038/cmi.2009.5
PMID:19254478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4002548/
Abstract

T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) has been reported to participate in the pathogenesis of inflammatory diseases. However, whether Tim-3 is involved in hepatitis B virus (HBV) infection remains unknown. Here, we studied the expression and function of Tim-3 in a hydrodynamics-based mouse model of HBV infection. A significant increase of Tim-3 expression on hepatic T lymphocytes, especially on CD8+ T cells, was demonstrated in HBV model mice from day 7 to day 18. After Tim-3 knockdown by specific shRNAs, significantly increased IFN-gamma production from hepatic CD8+ T cells in HBV model mice was observed. Very interestingly, we found Tim-3 expression on CD8+ T cells was higher in HBV model mice with higher serum anti-HBs production. Moreover, Tim-3 knockdown influenced anti-HBs production in vivo. Collectively, our data suggested that Tim-3 might act as a potent regulator of antiviral T-cell responses in HBV infection.

摘要

据报道,含T细胞免疫球蛋白和粘蛋白结构域分子3(Tim-3)参与炎症性疾病的发病机制。然而,Tim-3是否参与乙型肝炎病毒(HBV)感染仍不清楚。在此,我们在基于流体动力学的HBV感染小鼠模型中研究了Tim-3的表达和功能。在第7天至第18天的HBV模型小鼠中,肝T淋巴细胞尤其是CD8+T细胞上Tim-3的表达显著增加。在用特异性短发夹RNA敲低Tim-3后,观察到HBV模型小鼠肝CD8+T细胞产生的干扰素-γ显著增加。非常有趣的是,我们发现血清抗-HBs产生较高的HBV模型小鼠中,CD8+T细胞上的Tim-3表达更高。此外,Tim-3敲低影响体内抗-HBs的产生。总体而言,我们的数据表明Tim-3可能是HBV感染中抗病毒T细胞反应的有效调节因子。

相似文献

1
Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection.在乙型肝炎病毒感染小鼠模型中,阻断Tim-3信号通路可改善肝脏CD8+ T细胞产生干扰素-γ的情况。
Cell Mol Immunol. 2009 Feb;6(1):35-43. doi: 10.1038/cmi.2009.5.
2
The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.Tim-3/galectin-9 通路参与伴刀豆球蛋白 A 诱导的肝炎小鼠模型中肝调节性 T 细胞的稳态。
Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10.
3
Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.Tim-3在小鼠急性移植物抗宿主病中对肝脏CD8 + T细胞调节的优先作用。
J Immunol. 2006 Oct 1;177(7):4281-7. doi: 10.4049/jimmunol.177.7.4281.
4
Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中 T 细胞耗竭的 Tim-3/galectin-9 通路的上调。
PLoS One. 2012;7(10):e47648. doi: 10.1371/journal.pone.0047648. Epub 2012 Oct 24.
5
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.T 细胞免疫球蛋白和粘蛋白结构域分子 3(Tim-3)介导慢性乙型肝炎中自然杀伤细胞的抑制。
J Hepatol. 2010 Mar;52(3):322-9. doi: 10.1016/j.jhep.2009.12.005. Epub 2010 Jan 6.
6
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.TIM-3通路可改善泰勒氏鼠脑脊髓炎病毒诱导的脱髓鞘疾病。
Int Immunol. 2014 Jul;26(7):369-81. doi: 10.1093/intimm/dxt056. Epub 2014 Jan 31.
7
NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.自然杀伤细胞有助于在小鼠中诱导抗乙型肝炎病毒的CD8 + T细胞免疫。
J Immunol. 2016 May 15;196(10):4122-31. doi: 10.4049/jimmunol.1500846. Epub 2016 Apr 20.
8
Tim-3 blockade promotes iNKT cell function to inhibit HBV replication.TIM-3 阻断促进 iNKT 细胞功能抑制 HBV 复制。
J Cell Mol Med. 2018 Jun;22(6):3192-3201. doi: 10.1111/jcmm.13600. Epub 2018 Mar 30.
9
Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection.Tim-3 直接增强了 CD8 T 细胞对急性李斯特菌感染的反应。
J Immunol. 2014 Apr 1;192(7):3133-42. doi: 10.4049/jimmunol.1302290. Epub 2014 Feb 24.
10
Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.慢性乙型肝炎病毒感染患者T细胞上抗原依赖性和非依赖性因子对Tim-3表达的调节
Front Cell Infect Microbiol. 2017 Mar 28;7:98. doi: 10.3389/fcimb.2017.00098. eCollection 2017.

引用本文的文献

1
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
2
Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential.肝细胞癌治疗中靶向免疫检查点:迈向具有治愈潜力的联合策略
Exp Hematol Oncol. 2025 May 2;14(1):65. doi: 10.1186/s40164-025-00636-5.
3
Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver Parenchyma.胆管癌中的身体成分影响肿瘤及正常肝实质中的免疫细胞群体。
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102460. doi: 10.1016/j.jceh.2024.102460. Epub 2024 Nov 26.
4
CD38-Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells.不同启动子驱动的 CD38 特异性 CAR 整合到 CD38 基因座可导致 T 和 NK 细胞产生不同的抗肿瘤活性。
Adv Sci (Weinh). 2023 Sep;10(27):e2207394. doi: 10.1002/advs.202207394. Epub 2023 Jul 23.
5
Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection.Tim-3 表达变化可作为慢性乙型肝炎病毒感染肝组织病理变化监测预后的补充指标之一。
BMC Infect Dis. 2022 Nov 11;22(1):842. doi: 10.1186/s12879-022-07841-1.
6
An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation.TIM3 在慢性肾脏炎症中 T 细胞表达的新作用。
Front Immunol. 2022 Jan 26;12:798683. doi: 10.3389/fimmu.2021.798683. eCollection 2021.
7
Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development.空间分布和功能分析定义了 Tim-3/Tim-3 配体在肿瘤发展中的作用途径。
Mol Ther. 2022 Mar 2;30(3):1135-1148. doi: 10.1016/j.ymthe.2021.11.015. Epub 2021 Nov 19.
8
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.TIM3/Gal9 信号通路:癌症免疫治疗的一个新靶点。
Cancer Lett. 2021 Jul 10;510:67-78. doi: 10.1016/j.canlet.2021.04.011. Epub 2021 Apr 22.
9
Targeting novel inhibitory receptors in cancer immunotherapy.靶向癌症免疫治疗中的新型抑制性受体。
Semin Immunol. 2020 Jun;49:101436. doi: 10.1016/j.smim.2020.101436. Epub 2020 Dec 4.
10
Association of TIM-3 expression with glucose metabolism in Jurkat T cells.TIM-3 表达与 Jurkat T 细胞葡萄糖代谢的关联。
BMC Immunol. 2020 Aug 20;21(1):48. doi: 10.1186/s12865-020-00377-6.